0001140361-22-002188.txt : 20220120
0001140361-22-002188.hdr.sgml : 20220120
20220120160537
ACCESSION NUMBER: 0001140361-22-002188
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220119
FILED AS OF DATE: 20220120
DATE AS OF CHANGE: 20220120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BEDU-ADDO FRANK
CENTRAL INDEX KEY: 0001770756
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37568
FILM NUMBER: 22542373
MAIL ADDRESS:
STREET 1: 300 CONNELL DRIVE
STREET 2: SUITE 400
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PDS Biotechnology Corp
CENTRAL INDEX KEY: 0001472091
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264231384
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25B VREELAND ROAD
STREET 2: SUITE 300
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
BUSINESS PHONE: 800-208-3343
MAIL ADDRESS:
STREET 1: 25B VREELAND ROAD
STREET 2: SUITE 300
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
FORMER COMPANY:
FORMER CONFORMED NAME: Edge Therapeutics, Inc.
DATE OF NAME CHANGE: 20090911
4
1
form4.xml
FORM 4
X0306
4
2022-01-19
0001472091
PDS Biotechnology Corp
PDSB
0001770756
BEDU-ADDO FRANK
C/O PDS BIOTECHNOLOGY CORPORATION
25B VREELAND ROAD, SUITE 300
FLORHAM PARK
NJ
07932
true
true
President/CEO
Stock Option (Right to Buy)
6.28
2022-01-19
4
A
0
291500
0
D
2032-01-19
Common Stock
291500
291500
D
This option, representing a right to purchase a total of 291,500 shares of Common Stock, will become exercisable on January 19, 2023, with 25% vesting on that date and the remaining vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 19, 2026.
/s/ Frank Bedu-Addo
2022-01-20